Amrita Therapeutics Limited, a struck off public limited company, was established on 25 February 2008 in Ahmedabad, Gujarat, India. Engaging in biotechnology within the life sciences sector, it holds CIN: U24239GJ2008PLC053030. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹3.50 Cr and a paid-up capital of ₹2.40 Cr.
Formerly known as Amrita Therapeutics Private Limited. It upholds a active non-compliant status. Its leadership includes Himanshu Chimanlal Vyas (Director), Susan Kling Finston (Director), Mihirkumar Arvind Joshi (Nominee Director). Past directors included Himanshu Chimanlal Vyas, Vishnu Rajaram Varshney, Ananda Mohan Chakrabarty. Its latest AGM occurred on 29 September 2018, with the balance sheet filed on 31 March 2018. It is based at Outer Room, 11, Devipark Co-Op. Housing Society B/H Lake View Appt., Vastrapur., Ahmedabad, Gujarat, 380054.
U24239GJ2008PLC053030
053030
25 February 2008
₹3.50 Cr
₹2.40 Cr
Roc Ahmedabad
Unlisted
Struck Off
Explore comprehensive insights into Amrita Therapeutics Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Himanshu Chimanlal Vyas | Director | 12 Aug 2008 | Current |
| Susan Kling Finston | Director | 25 Feb 2008 | Current |
| Mihirkumar Arvind Joshi | Nominee Director | 31 Jul 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 08 Nov 2019 | Past |
| Pramod Abcsdd | Director | 29 Jul 2009 | Past |
| Pramod Abcsdd | Director | 27 Oct 2008 | Past |
| Pramod Abcsdd | Managing Director | 27 Oct 2017 | Past |
| Pramod Abcsdd | Nominee Director | 24 Apr 2019 | Past |
| Pramod Abcsdd | Director | 25 Sep 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Amrita Therapeutics Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2018, Amrita Therapeutics had a promoter holding of 41.10% and a public holding of 58.89%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Amrita Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Amrita Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amrita Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Amrita Therapeutics Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records. was documented.
Progress on Amrita Therapeutics Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Ahmedabad. was documented.
Progress on Mihirkumar Arvind Joshi was appointed as a Nominee Director was appointed as a Nominee Director on 31 Jul 2009 & has been associated with this company since 16 years 4 months . was documented.
Progress on Himanshu Chimanlal Vyas was appointed as a Director was appointed as a Director on 12 Aug 2008 & has been associated with this company since 17 years 3 months . was documented.
The activity Susan Kling Finston was appointed as a Director was appointed as a Director on 25 Feb 2008 & has been associated with this company since 17 years 9 months . was completed.
Amrita Therapeutics Limited was registered on 25 Feb 2008 with Roc Ahmedabad & aged 17 years 9 months as per MCA records. was recorded as a recent event.
The CIN of Amrita Therapeutics Limited is U24239GJ2008PLC053030.
Amrita Therapeutics Limited is headquartered at Outer Room, 11, Devipark Co-Op. Housing Society B/H Lake View Appt., Vastrapur., Ahmedabad, Gujarat, 380054.
Amrita Therapeutics Limited was incorporated on 25 February 2008.
The current directors of Amrita Therapeutics Limited are
The primary industry of Amrita Therapeutics Limited is Life Sciences.
Amrita Therapeutics Limited is unlisted.
The authorized capital of Amrita Therapeutics Limited is ₹3.50 Cr, and the paid-up capital is ₹2.40 Cr.
The compliance status of Amrita Therapeutics Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX